Fetal Life
Smart devices for healthier pregnancies.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | - | 133 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Fetal Life is a healthcare company focused on providing comprehensive care throughout the entire pregnancy journey and postpartum period. The company integrates medical devices, telehealth capabilities, data analysis, and artificial intelligence to offer a holistic approach to maternal care. Fetal Life serves expecting mothers and healthcare providers, operating in the maternal healthcare market. The business model includes a free mobile app with in-app purchases and premium subscription features, such as nurse monitoring, health measurement reports, and clinically approved care plans powered by AI. The company generates revenue through these premium subscriptions and the sale of patented medical devices like contraction monitoring devices and fetal heartbeat monitors. Fetal Life aims to ensure continuous care between physician visits, reduce urgent care issues, and provide immediate access to medical help 24/7.
Keywords: maternal care, telehealth, AI, data analytics, pregnancy, postpartum, medical devices, telemonitoring, premium subscription, healthcare.